Comprehensive overview of toxoplasma gondii-induced and associated diseases

dc.contributor.authorDaher, Darine
dc.contributor.authorShaghlil, Ahmad
dc.contributor.authorSobh, Eyad
dc.contributor.authorHamie, Maguy H.
dc.contributor.authorHassan, Malika Elhage
dc.contributor.authorMoumneh, Mohamad Bahij M.
dc.contributor.authorItani, Shaymaa
dc.contributor.authorEl Hajj, Rana H.
dc.contributor.authorTawk, Lina
dc.contributor.authorEl-Sabban, Marwan E.
dc.contributor.authorEl-Hajj, Hiba Ahmad
dc.contributor.departmentExperimental Pathology, Microbiology, and Immunology
dc.contributor.departmentAnatomy, Cell Biology, and Physiological Sciences
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:39:06Z
dc.date.available2025-01-24T11:39:06Z
dc.date.issued2021
dc.description.abstractToxoplasma gondii (T. gondii) is a prevalent protozoan parasite of medical and veterinary significance. It is the etiologic agent of toxoplasmosis, a neglected disease in which incidence and symptoms differ between patients and regions. In immunocompetent patients, toxoplasmosis manifests as acute and chronic forms. Acute toxoplasmosis presents as mild or asymptomatic disease that evolves, under the host immune response, into a persistent chronic disease in healthy individuals. Chronic toxoplasmosis establishes as latent tissue cysts in the brain and skeletal muscles. In immunocompromised patients, chronic toxoplasmosis may reactivate, leading to a potentially life-threatening condition. Recently, the association between toxoplasmosis and various diseases has been shown. These span primary neuropathies, behavioral and psychiatric disorders, and different types of cancer. Currently, a direct pre-clinical or clinical molecular connotation between toxoplasmosis and most of its associated diseases remains poorly understood. In this review, we provide a comprehensive overview on Toxoplasma-induced and associated diseases with a focus on available knowledge of the molecular players dictating these associations. We will also abridge the existing therapeutic options of toxoplasmosis and highlight the current gaps to explore the implications of toxoplasmosis on its associated diseases to advance treatment modalities. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
dc.identifier.doihttps://doi.org/10.3390/pathogens10111351
dc.identifier.eid2-s2.0-85118244303
dc.identifier.urihttp://hdl.handle.net/10938/29178
dc.language.isoen
dc.publisherMDPI
dc.relation.ispartofPathogens
dc.sourceScopus
dc.subjectBehavioral disorders
dc.subjectNeurological disorders
dc.subjectNeuropathies
dc.subjectPsychiatric disorders
dc.subjectToxoplasmosis
dc.subjectAcute toxoplasmosis
dc.subjectAlzheimer disease
dc.subjectBehavior disorder
dc.subjectBrain cancer
dc.subjectCongenital toxoplasmosis
dc.subjectDepression
dc.subjectEpilepsy
dc.subjectHigh throughput sequencing
dc.subjectHuman
dc.subjectImmunocompromised patient
dc.subjectMultiple sclerosis
dc.subjectNeuropathy
dc.subjectNonhuman
dc.subjectObsessive compulsive disorder
dc.subjectOcular toxoplasmosis
dc.subjectParkinson disease
dc.subjectPsychosis
dc.subjectReview
dc.subjectSchizophrenia
dc.subjectToxoplasma gondii
dc.titleComprehensive overview of toxoplasma gondii-induced and associated diseases
dc.typeReview

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2021-5820.pdf
Size:
1.3 MB
Format:
Adobe Portable Document Format